Newsroom

Sorted by: Latest

-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Nasdaq Clean Edge Smart Grid Infrastructure UCITS ETF 22.12.2025 GRDU.LN IE000J80JTL1 20,750,002.00 USD 1,104,033,961.59 53.206  ...
-

American Heart Association (AHA) Scientific Sessions Highlights Report 2025: Indications, Companies, and Therapies Focus on GLP-1RAs, Hyperlipidemia, Heart Failure, Pulmonary Arterial Hypertension - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "American Heart Association (AHA): Scientific Sessions 2025 Highlights" report has been added to ResearchAndMarkets.com's offering. AHA 2025 took place in New Orleans, Louisiana, between 7-10 November 2025. The American Heart Association (AHA) Scientific Sessions is an annual, four-day conference that brings together cardiovascular healthcare professionals from around the world to share the latest advances, research, and guidelines in heart and vascular medicine. Th...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Alerian Disruptive Technology Real Estate UCITS ETF 22.12.2025 LANDXN.LN IE000RN036E0 28,035.00 USD 564,171.60 20.124  ...
-

Zai Lab Announces Approval of COBENFY (xanomeline and trospium chloride) in China, a First-in-Class Therapy for Schizophrenia

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that China’s National Medical Products Administration (NMPA) approved the New Drug Application (NDA) for COBENFY® (xanomeline and trospium chloride) for the treatment of schizophrenia in adults. COBENFY is the first schizophrenia therapy with a novel mechanism of action approved in over 70 years [1], offering a fundamentally new approach to treating schizophrenia. By selectively activating M...
-

Arrowhead Pharmaceuticals to Participate in Upcoming January 2026 Events

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events: Obesity KOL Webinar – ARO-INHBE and ARO-ALK7 Interim Clinical Data – January 6, 2026 Type: Company KOL Webinar Date/Time: January 6, 2026, 11:30 a.m. EST J.P. Morgan 2026 Healthcare Conference – January 12-15, 2026 Type: Corporate Presentation Date/Time: January 12, 2026, 10:30 a.m. EST Presentation materials and webcast links, i...
-

The Global Aerogels Market 2026-2036: Manufacturing Scalability, Cost Structures, Competitive Dynamics, Emerging Application Opportunities - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "The Global Aerogels Market 2026-2036" has been added to ResearchAndMarkets.com's offering. The Global Aerogels Market 2026-2036 provides strategic intelligence for materials manufacturers, end-users, investors, and technology developers navigating this rapidly evolving market. Analysis encompasses silica, polymer, carbon, and bio-based aerogel technologies, examining manufacturing scalability, cost structures, competitive dynamics, and emerging application opportun...
-

Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders, Executive Vice President and Chief Financial Officer Sam Eldessouky and Chief Medical Officer and Head of Research & Development Yehia Hashad, MD, will participate in a company presentation at the 44th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026, at...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Value Line Dividend Index UCITS ETF 22.12.2025 FVD. IE00BKVKW020 250,002.00 USD 7,035,954.70 28.144  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Capital Strength ESG Leaders UCITS ETF 22.12.2025 FCSG IE00BKPSPT20 1,425,002.00 USD 62,382,094.09 43.777  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust NASDAQ Clean Edge Green Energy UCITS ETF 22.12.2025 QCLN.LN IE00BDBRT036 525,002.00 USD 9,521,561.31 18.136  ...